Walleye Trading’s Bionano Genomics BNGO Stock Holding History

Walleye Trading’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-158	Closed	-$756K	–	4652
2018 Q3	$756K	Buy	+158	New	+$674K	﹤0.01%	2416

Other funds holding BNGO

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Walleye Trading's BNGO Position: Q4 2018 in Review

Walleye Trading sold out of Bionano Genomics (BNGO) in Q4 2018, closing a stake of 158 shares — an estimated $756K sold.

Walleye Trading first reported a position in BNGO in Q3 2018 and held it in 1 quarter. The position peaked at $756K in Q3 2018. 11 funds tracked by Wall St. Rank hold BNGO as of Q4 2018.

Walleye Trading reported no remaining Bionano Genomics position as of Q4 2018 after selling out during the quarter.
Walleye Trading sold 158 Bionano Genomics shares in Q4 2018, an estimated $756K.
Walleye Trading first reported a position in Bionano Genomics in Q3 2018 and held it in 1 quarter.
Walleye Trading's Bionano Genomics position peaked at $756K in Q3 2018.
11 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.